Evidence map›Paper›PMID 19451219›Full record

ArticleGenes & development2009

Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice.

Yi-Fan Chen, Cheng-Heng Kao, Ya-Ting Chen, Chih-Hao Wang, Chia-Yu Wu, Ching-Yen Tsai, Fu-Chin Liu, Chu-Wen Yang, Yau-Huei Wei, Ming-Ta Hsu and 2 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Genes & development, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02882477 (Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone, and Incretin Based Therapy), which is not on this map. Cited by 159 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02882477 phase2 / phase3unknown statusstarted 2016, after this paper: background citation

Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone, and Incretin Based Therapy

Ran2016Enrolled20Registered outcomes6Posted comparisons0ConditionsDiabetes Mellitus, Gastroduodenal Ulcer, Iron Metabolism Disorders, Optic AtrophyArmsacetylcysteine, Deferiprone, Sitagliptin and Metformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 6 syntheses or guidelines pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. A probioticGut microbes · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Neonatal and Syndromic Forms of Diabetes.Current diabetes reports · 2025
    Review
  19. Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yi-Fan ChenDepartment of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Cheng-Heng Kao
Ya-Ting Chen
Chih-Hao Wang
Chia-Yu Wu
Ching-Yen Tsai
Fu-Chin Liu
Chu-Wen Yang
Yau-Huei Wei
Ming-Ta Hsu
Shih-Feng Tsai
Ting-Fen Tsai
National Yang Ming University Hospital · TWNational Yang Ming Chiao Tung University · TWChang Gung University · TWSoochow University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CISD2, the causative gene for Wolfram syndrome 2 (WFS2), is a previously uncharacterized novel gene. Significantly, the CISD2 gene is located on human chromosome 4q, where a genetic component for longevity maps. Here we show for the first time that CISD2 is involved in mammalian life-span control. Cisd2 deficiency in mice causes mitochondrial breakdown and dysfunction accompanied by autophagic cell death, and these events precede the two earliest manifestations of nerve and muscle degeneration; together, they lead to a panel of phenotypic features suggestive of premature aging. Our study also reveals that Cisd2 is primarily localized in the mitochondria and that mitochondrial degeneration appears to have a direct phenotypic consequence that triggers the accelerated aging process in Cisd2 knockout mice; furthermore, mitochondrial degeneration exacerbates with age, and the autophagy increases in parallel to the development of the premature aging phenotype. Additionally, our Cisd2 knockout mouse work provides strong evidence supporting an earlier clinical hypothesis that WFS is in part a mitochondria-mediated disorder; specifically, we propose that mutation of CISD2 causes the mitochondria-mediated disorder WFS2 in humans. Thus, this mutant mouse provides an animal model for mechanistic investigation of Cisd2 protein function and help with a pathophysiological understanding of WFS2.

Indexed as

AgingAging, PrematureAnimalsAutophagyAutophagy-Related ProteinsCarrier ProteinsDisease Models, AnimalFemaleGlucose IntoleranceHumansLongevityMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaAutophagy-Related ProteinsCarrier ProteinsMitochondrial ProteinsNerve Tissue ProteinsNoxp70 protein, mouse

Identifiers

PMID19451219
PMCPMC2685531
OpenAlexW2144377119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.